Steward Partners Investment Advisory, LLC

Position in LFCR — Lifecore Biomedical, Inc. \De\

CIK 1723397 STAMFORD, CT

Back to LFCR Full portfolio

Position in LFCR

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$127,510

-$152,368 QoQ

Shares Held

34,277

+0.2% QoQ

Ownership

0.091%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Steward Partners Investment Advisory, LLC holds $17,740,255 across 32 Drug Manufacturers - Specialty & Generic names. LFCR ranks #10 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	93,714	$11,077,931
2	HROW	Harrow, Inc.	90,629	$3,195,578
3	LNTH	Lantheus Holdings, Inc.	12,382	$939,174
4	PCRX	Pacira BioSciences, Inc.	30,419	$687,469
5	PBH	Prestige Consumer Healthcare Inc.	7,070	$419,038
6	HLN	Haleon plc	41,252	$412,932
7	VTRS	Viatris Inc	13,644	$184,330
8	UTHR	UNITED THERAPEUTICS Corp	253	$150,023

All Filings in LFCR

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$127,510	34,277	+0.2%	Shares	Sole	2026-05-08
2025-12-31	$279,878	34,215	+1.0%	Shares	Sole	2026-02-12
2025-09-30	$249,423	33,889	+3.4%	Shares	Sole	2025-11-12
2025-06-30	$266,019	32,761	+8.4%	Shares	Sole	2025-08-12
2025-03-31	$212,840	30,233	+11.2%	Shares	Sole	2025-05-13
2024-12-31	$201,977	27,184	+61.2%	Shares	Sole	2025-02-06
2024-09-30	$83,139	16,864	+116.9%	Shares	Sole	2024-11-14
2024-06-30	$39,890	7,776	+83.4%	Shares	Sole	2024-08-08
2024-03-31	$22,519	4,241	+105.5%	Shares	Sole	2024-05-15
2023-12-31	$12,776	2,064	+148.7%	Shares	Sole	2024-02-12
2023-09-30	$6,266	830	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.